Trending...
- TradeTek 3.3 Generates Accurate Construction Quotes Faster
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
FAYETTEVILLE, Ark. - nvtip -- Lineus Medical, a leader in vascular access innovation and maker of SafeBreak® Vascular, the first breakaway device for IV lines, today announced the renewal of its agreement with Vizient, one of the nation's largest group purchasing organization (GPO). The renewed contract delivers more competitive pricing for Vizient members, expanding access to SafeBreak Vascular across health systems nationwide.
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on nvtip.com
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
The agreement enables Vizient member hospitals to procure SafeBreak Vascular at advantaged pricing, lowering the barrier to adoption for health systems focused on reducing IV complications, protecting patients, and driving clinical and economic value at the bedside.
"This renewal reflects our commitment to making SafeBreak Vascular accessible to every nurse and patient," said Vance Clement, Chief Executive Officer of Lineus Medical. "Our mission is to remove the pains associated with medical lines, and our Vizient agreement allows us to run that mission into action at scale."
"The Vizient relationship is a critical part of our commercial strategy," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "More competitive pricing means more health systems can say "Yes" to SafeBreak Vascular. That translates directly into more patients protected, more nurses supported, and improved clinical and economic outcomes for every hospital that utilizes SafeBreak."
More on nvtip.com
- New Research Identifies "The Great Junk Transfer": 49% of Americans Would Rather Inherit Nothing Than Sort Through a Relative's Belongings
- Minus K Technology launches it Educational Giveaway for Universities and Colleges in the USA
- GO NATURAL® 27 Year Anniversary -- One Woman. One Idea. One Product That Changed Everything
- UK Financial Ltd Verifies Maya Preferred PRA Circulating Supply, Proving Its Eight-Year Promise of Under 1M Tokens After Chainlink Labs Agreement
- 2027 Nissan Rogue Hybrid Coming Soon to 777 Nissan in Las Vegas, NV
SafeBreak® Vascular is a breakaway device for IV lines that separates when a damaging force is applied to the IV line to remove the damaging force and protect the patient's IV line. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. SafeBreak has been shown to reduce mechanical IV complications in a range of 44% to 91%.1 The device is FDA-cleared for use across all vascular access lines, CE Mark certified for use across the European Union, and is distributed across markets spanning more than three continents.
About Lineus Medical Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
About Vizient Vizient, Inc. is the nation's largest group purchasing organization (GPO), serving member health systems, academic medical centers, community hospitals, and other health care providers. Through its contract portfolio, Vizient aggregates the purchasing power of its members to deliver cost savings and supply chain solutions across the continuum of care.
Reference:
1. Data on File
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on nvtip.com
- The 'Tax Squeeze': Betsson's Record Quarter Previews the Economics of Finland's 2027 Casino Market
- We Have The Power Is Building Better Communities Through Dialogue, Ethics, And Engagement
- ImagineX Acquires Payteros to Strengthen Digital Transformation Capabilities
- From Pizza to Playlists: Marty The Pizza Guy Delivers Three Delicious New Songs
- Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof
- Phinge Notifies Parties in Apple v. Liu it is Exploring Amicus Curiae Submission Regarding its Foundational App-less & Hardware Verified Technologies
- K2 Integrity Names Michael Kallabat Global Head of Investigations and Disputes
- Socialhose Eyes Southeast Asia and Rejects the Copy-Paste Expansion Playbook
- $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
- Tax Lien and Deed Group, LLC Announces Launch of Specialized Real Estate Investment Fund
- Phinge Home Of Netverse & Verified NI, Is Expanding Its App-less & Hardware Verification Patent Portfolio By Filing Over 1000 New Patent Applications
- TradeTek 3.3 Generates Accurate Construction Quotes Faster
- Nevada Boxing Hall of Fame Introduces Five Inaugural Special Awards Honoring Boxing's Legacy Beyond the Ring
- $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
- Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
- Next Gen Fibre Selects netElastic vBNG and CGNAT to Fuel Rapid Nationwide Expansion and Eliminate Network Bottlenecks
- Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract


